Technological and Traditional Approaches to Prevent Childhood Obesity
in Schoolchildren Aged 6 to 16 in Spain
Led by Universidad de Córdoba · Updated on 2024-06-11
215
Participants Needed
1
Research Sites
2 weeks
Total Duration
AI-Summary
What this Trial Is About
Childhood obesity is a growing public health issue worldwide and especially in Spain, where it is more prevalent in southern regions. Factors contributing to this include dietary habits, physical inactivity, socioeconomic status, and family environment. The study aims to evaluate the impact of a nutritional intervention administered by school nurses to address childhood obesity and its health consequences, including heart and musculoskeletal issues.
The study compares two groups of schoolchildren aged 6 to 16. One group receives a technological intervention using podcasts, gamification, and virtual reality to promote nutrition education and healthy behaviors. The control group receives traditional brochures with nutritional information. Both groups are monitored through various measurements and biometric data collected over a 15-month period.
Participants will be assessed regularly for weight, height, body composition, circumference measures, blood pressure, and adherence to the Mediterranean diet using questionnaires. Additional evaluations include a 3D avatar system for anthropometric measures. The study includes data collection at multiple timepoints from 12 weeks up to 15 months, with ongoing monitoring to assess the effectiveness of the intervention and potential health improvements.
CONDITIONS
Brief Title
A New Technological Intervention to Address Childhood Obesity:
Research Team
M
Manuel J Guzmán Roldán, Msc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
Collaborating Sponsor
Who Can Participate
Age: 6Years - 16Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Students from the school
Children aged 6 to 16 years
Students with confirmed approval to participate
Signed informed consent by the minor
Signed informed consent by the minor's parents or guardians
You will not qualify if you...
HbA1c levels below 5.7%
HbA1c levels above 6.4%
Presence of metabolic diseases such as diabetes or metabolic syndrome
Presence of diseases related to intestinal integrity or skin issues
Lack of signed informed consent by the minor and legal guardian
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 15 months
Participants receive a nutritional intervention through either a technological combination including workshops, counseling, cooking classes, and physical activity promotion, or a traditional brochure-based intervention to support healthy eating habits and lifestyle changes.
Regular assessments approximately every 3 months during the 15 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
PILI 0ina Project to Improve Diet and Health in Native Hawaiian Adults with Cardiometabolic Conditions Through Community Cooking Demonstrations
100-Year Human Aging Study Long-Term Follow-Up of Multi-System Health Measures to Predict Mortality and Aging Outcomes
Technological and Traditional Approaches to Prevent Childhood Obesity
in Schoolchildren Aged 6 to 16 in Spain
Phase 3 Clinical Trial of Intravenous AOC 1044 to Treat Duchenne Muscular Dystrophy in Boys Aged 7 to 16 with Exon 44 Skipping Mutations
Phase 1 Study to Evaluate the Safety of CTX310, a CRISPR-Based Treatment,
for Adults 18 to 75 Years Old with Hard-to-Treat Dyslipidemias
Phase 2b Study to Test Safety and Effectiveness of PF-08653945 and PF-08653944 Alone or Together for Weight Loss in Adults with Overweight or Obesity
Phase 3 Study of HST101 Lerodalcibep Given by Injection Every 4 Weeks to Treat Chinese Adults with High Cholesterol and Heart Disease Risk
Observational Study on Effectiveness and Safety of Switching to Pevarozet Tablet
in Adults With Hypercholesterolemia Previously Treated With Atorvastatin or Rosuvastatin
Overcoming Barriers to Preventing and Treating Cardiometabolic Disorders
in People Living With HIV in the Southeastern United States
Study of Atorvastatin and Omega-3 Combination Therapy to Treat Carotid Artery Disease in Adults With Type 2 Diabetes and Mixed Dyslipidemia